Brain wave and inflammation markers in shock therapy for depression
Part of Mental health clinical trials.
This study looks at brain wave patterns and markers of inflammation in people with depression that hasn't improved with other treatments and who are receiving electroconvulsive therapy (ECT, also known as shock therapy). The goal is to understand how these markers might relate to how well ECT works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with major depressive disorder and are currently having a major depressive episode.
- Your doctor has recommended ECT (electroconvulsive therapy, sometimes called shock therapy) for your depression.
- You have not had ECT or TMS (a brain stimulation treatment) in the past month.
- You do not have a history of schizophrenia, bipolar disorder, certain neurological conditions, or recent heart or brain problems.
- You are willing to participate and provide written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This study tests a treatment called transcranial magnetic stimulation (TMS), which uses magnetic pulses to stimulate areas of the brain involved in mood. It aims to see if TMS can help people with depression by improving how they cope with stress and daily functioning.
This study measures how brain activity in specific regions changes after you receive electroconvulsive therapy (ECT) or magnetic seizure therapy (MST) for severe depression. Researchers use a non-invasive headband to monitor blood flow in your brain before and after treatment to better understand how these therapies work.
This study compares two brain stimulation treatments—Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT)—to see which works better for severe depression. If you are on a stable antidepressant and haven't had recent brain stimulation, this trial may be an option for you.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study tests a non-invasive brain stimulation treatment for people with major depression who still have symptoms despite treatment. It aims to see if this approach can help improve mood and reduce residual symptoms.
Hear when a new Major Depression Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.